Sonoma Pharmaceuticals (SNOA) Inventory (2011 - 2026)

Sonoma Pharmaceuticals' Inventory history runs 16 years deep, the most recent figure standing at $3.7 million for Q1 2026.

• On a quarterly basis, Inventory rose 13.63% year-over-year to $3.7 million in Q1 2026; TTM through Mar 2026 was $3.7 million, a 13.63% increase from a year earlier, with the FY2026 full-year figure at $3.7 million, up 13.63% from the prior year.
• Inventory declined to $3.7 million in Q1 2026 per SNOA's latest filing, from $3.7 million in the prior quarter.
• Across five years, Inventory topped out at $3.8 million in Q2 2025 and bottomed at $2.5 million in Q3 2023.
• The 5-year median for Inventory is $3.0 million (2024), against an average of $3.1 million.
• Across the five-year window, Inventory decreased 16.93% in 2023 and soared 30.21% in 2025, its largest moves.
• Year by year, Inventory stood at $2.8 million in 2022, then gained by 3.72% to $3.0 million in 2023, then rose by 6.36% to $3.1 million in 2024, then rose by 17.82% to $3.7 million in 2025, then decreased by 1.4% to $3.7 million in 2026.
• Per Business Quant, the three latest SNOA Inventory figures stand at $3.7 million (Q1 2026), $3.7 million (Q4 2025), and $3.6 million (Q3 2025).